Cancer Biomarkers

cancer growth development biomarker implies a substance or method that is definite of the proximity of infection in the body. A biomarker may be an iota released by a cancer or a specific response of the body to the closeness of harm. Inherited, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer growth development assurance, perception, and the investigation of infection transmission. Such biomarkers is tried in non-prominently accumulated bio liquids like blood or fluid body substance.

Various quality and protein based biomarkers have recently been used in the end in open minded thought; including,

  • AFP (Liver Cancer)
  • BCR-ABL (Chronic Myeloid Leukemia)
  • BRCA1/BRCA2 (Breast/Ovarian Cancer)
  • BRAF V600E (Melanoma/Colorectal Cancer)

    Related Conference of Cancer Biomarkers

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in